Physician

Shamim Z Jilani, MD

According to 2025 Medicare claims, Shamim Jilani, MD (NPI: 1801842364) practices medical oncology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON PHYSICIANS, LLC (NPI: 1902844947; TIN: 203130844) and primary practice location at 45415-1333. Jilani is affiliated with the Health Centers of Ohio ACO LLC (ACO ID: A5411), participating under the MSSP model.

Jilani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 414 traditional Medicare patients, billed 70,613 HCPCS/CPT codes, and received $1,421,867 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 724 prescription claims across 149 beneficiaries totaling $2,917,689 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 27 claims. Open Payments data shows 45 records totaling $916. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $796,724 and ending at $1,421,867. Concurrently, Part D prescription costs have risen steadily, from $1,589,822 to $2,917,689. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	545	75,793	$796,724
2016	606	97,426	$1,282,432
2017	680	112,886	$1,552,858
2018	693	103,880	$1,596,617
2019	738	134,227	$1,799,141
2020	647	137,736	$2,161,966
2021	608	126,290	$2,092,763
2022	546	93,158	$1,557,611
2023	432	104,626	$2,087,139
2024	414	70,613	$1,421,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	1,354	$1,589,822
2016	286	1,340	$1,883,403
2017	300	1,459	$2,211,700
2018	266	1,215	$2,106,033
2019	261	1,401	$2,931,048
2020	227	1,092	$3,460,814
2021	185	820	$3,297,560
2022	133	482	$2,187,205
2023	191	923	$2,998,395
2024	149	724	$2,917,689

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$626
2016	N/R	68	$13,455
2017	N/R	89	$14,878
2018	N/R	100	$13,135
2019	N/R	80	$7,936
2020	N/R	59	$3,459
2021	N/R	71	$2,649
2022	N/R	27	$805
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	64	65	$829
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	52	53	$627
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	107	307	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	58	64	$56
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	80	10,600	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	17	476	$389,613
Calquence	Acalabrutinib Maleate	29	870	$382,116
Xtandi	Enzalutamide	20	600	$277,426
Lenalidomide	Lenalidomide	19	532	$267,080
Revlimid	Lenalidomide	14	392	$259,381

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$916	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shamim Z. Jilani, MD?

Tedicare shows public-source Medicare data for Shamim Z. Jilani, MD (NPI 1801842364), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shamim Z. Jilani, MD have ACO affiliation data?

Shamim Z. Jilani, MD is shown with ACO affiliation data for Health Centers of Ohio ACO LLC (MSSP, ACO ID A5411).

What billing organization is linked to Shamim Z. Jilani, MD?

Shamim Z. Jilani, MD is linked to DAYTON PHYSICIANS, LLC (billing NPI 1902844947) in the available physician profile data.

Does Shamim Z. Jilani, MD have Open Payments data?

Shamim Z. Jilani, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.